中山醫學大學機構典藏 CSMUIR:Item 310902500/3670
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 17901/22917 (78%)
造访人次 : 7621798      在线人数 : 452
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.csmu.edu.tw:8080/ir/handle/310902500/3670


    题名: 基因表觀遺傳機制調控麩胱甘肽轉移酶在肺癌細胞及早期非小細胞肺癌患者中的表現之研究
    Epigenetic mechanisms for silence of Glutathione S-transferase M2 expression by hypermethylated Sp1 binding in lung cancer
    作者: 湯曉君
    Sheau-Chung Tang
    贡献者: 中山醫學大學:中山醫學大學醫學研究所;柯俊良
    关键词: 麩胱甘肽轉移酶;肺癌;專一性蛋白1;DNA甲基化;DNA 甲基轉移酶
    Glutathione S-transferases;lung cancer;specificity protein 1;DNA methylation;DNA methyltransferase
    日期: 2011
    上传时间: 2011-03-29T07:15:51Z (UTC)
    摘要: 背景:麩胱甘肽轉移酶 (Glutathione S-transferase, GST) 是一種解毒酵素。GST-M2的低表現在肺癌細胞可以被偵測到；然而，GST-M2在肺癌細胞中調控機制並不清楚。在本研究中，我們探討在肺癌細胞中的GST-M2的表觀調控機制(epigenetic mechanism)。方法:在肺癌細胞以DNA甲基轉移酵素 (DNA methyltransferase；DNMT)抑制劑5’-aza-2’-deoxycytidine (5’-Aza-dC) 處理後，我們評估GST-M2的啟動子甲基化；Reporter activity assay、Chromatin immunoprecipitation (ChIP)、electrophoretic mobility-shift assay (EMSA) 以及shRNA 試驗被使用來測試是否Sp1甲基化影響結合在GST-M2 啟動子上，並且調控GST-M2的轉譯。即時定量PCR (real-timePCR)也被運用來決定73名非小細胞肺癌(non-small cell lung cancer [NSCLC])組織中，GST-M2與DNMT-3b mRNA程度。在肺癌細胞中，藉由5’-Aza-dC的處理，GST-M2的基因表現被回復；在肺癌細胞及非小細胞肺癌組織中，GST-M2也表現出高度的啟動子甲基化程度。結果:在肺癌細胞中，CpG甲基化減弱了Sp1結合至GST-M2啟動子。在肺部正常細胞中，Sp1的剔除減少了GST-M2的表現；並且在肺癌細胞中，DNMT-3b的靜默則增加了GST-M2的表現。此外，在具有低GST-M2表現的肺部腫瘤中相較於具有高GST-M2的肺部腫瘤中，DNMT-3b表現是顯著較高的，特別是女性與第一期病患分組。結論:GST-M2的表觀靜默能夠被辨識出Sp1調控的GST-M2轉譯表現，並且代表著導致在肺癌細胞和第一期NSCLC病患中所觀察到的GST-M2減少表現之機制。
    BACKGROUND:Glutathione S-transferases M2 (GST-M2) is a detoxifying enzyme. Low expression of GST-M2 in lung cancer cells was detected. However, little is known about the regulation of GST-M2 in lung cancer cells. In this study, we investigated the epigenetic regulatory mechanisms of GST-M2 in lung cancer cells. METHODS:We evaluated the promoter methylation of GST-M2 following the DNA methyltransferase (DNMT) inhibitor, 5’-aza-2’-deoxycytidine (5’-aza-dC) treatment in lung cancer cells. Reporter activity assay, Chromatin immunoprecipitation (ChIP), electrophoretic mobility-shift assay (EMSA) and small interfering RNA (siRNA) assays were used to detect whether methylation of Sp1 affects the binding to the GST-M2 promoter and regulates GST-M2 transcription. Real-time PCR was applied to determine GST-M2 and DNMT-3b mRNA levels in 73 non-small cell lung cancer (NSCLC) tissues. RESULTS:GST-M2 expression was restored by the treatment with 5’-aza-dC in lung cancer cells. GST-M2 also exhibited high frequency of promoter hypermethylation in lung cancer cells and NSCLC tumor tissues. CpG hypermethylation abated Sp1 binding to the GST-M2 promoter in lung cancer. Knockdown of Sp1 in lung normal cells reduced GST-M2 expression, and silencing of DNMT-3b increased GST-M2 expression in lung cancer cells. In addition, DNMT-3b expression was significantly higher in lung tumors with low GST-M2 expression than that in lung tumors with high GST-M2 expression, especially in female and stage I groups. CONCLUSIONS: Epigenetic silencing of GST-M2 could be distinguished Sp1 mediated GST-M2 transcriptional expressions and represent the mechanism leading to the decreased expression of GST-M2 observed in lung cancer cells and stage I/II NSCLC patients.
    URI: https://ir.csmu.edu.tw:8080/handle/310902500/3670
    显示于类别:[醫學研究所] 博碩士論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    index.html0KbHTML307检视/开启


    SFX Query

    在CSMUIR中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈